在炎症性肠道疾病中,有机体作为再生药物
Alexander Hammerhøj1, Deepavali Chakravarti2, Toshiro Sato3
1Department of Gastroenterology, Herlev Hospital, University of Copenhagen, Herlev, Denmark.
iScience
|July 1, 2024
概括
通过肠道器官移植,可以改善炎症性肠病 (IBD) 的管理. 这种再生疗法在早期人类试验中显示出组织修复和功能恢复的前景.
科学领域:
- 胃肠道学和再生医学
- 干细胞生物学和组织工程
背景情况:
- 炎症性肠病 (IBD) 是一种慢性疾病,其全球流行率正在上升.
- 目前用于IBD的药理疗法在有效性和适用性方面存在局限性.
- 对于管理IBD活动的新型治疗策略有着至关重要的需求.
研究的目的:
- 探索肠道器官移植作为IBD的新生再生治疗选择的潜力.
- 提供关于这种新兴疗法的必要性和临床应用的见解.
- 讨论在临床环境中与肠道器官移植相关的挑战.
主要方法:
- 使用内镜获得的肠道活检标本用于有机体生成.
- 进行涉及小鼠和人类器官移植的实验研究.
- 分析正在进行的人类临床试验中的有机体治疗的结果.
主要成果:
- 实验性移植显示出有希望的组织再生和功能恢复.
- 早期的人体试验已经开始,这表明临床转化取得了进展.
- 肠道器官移植显示出作为一种可行的再生方法的潜力.
结论:
- 肠道器官移植代表了IBD管理的有希望的新前沿.
- 这种再生疗法为组织修复和改善患者结果提供了潜在的潜力.
- 需要进一步的研究和临床开发,以克服相关的挑战.
更多相关视频
相关概念视频
01:23Renewal of Intestinal Stem Cells
2.5K
The intestinal epithelial lining rapidly renews every 4 to 5 days. The renewal is facilitated by intestinal stem cells (ISCs) located at the base of the crypt– a gland located at the bottom of each villus. ISCs divide asymmetrically to form new stem cells and progenitor daughter cells. The daughter cells are called transit-amplifying (TA) cells which move upwards along the crypt and either differentiate into absorptive cells– the enterocytes or secretory cells– including the...
2.5K
01:21Inflammatory Bowel Disease V: Surgical Management
139
Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:
Here are some common surgical interventions for IBD:
139